1
|
Subotic-Kerry M, Werner-Seidler A, Corkish B, Batterham PJ, Sicouri G, Hudson J, Christensen H, O'Dea B, Li SH. Protocol for a randomised controlled trial evaluating the effect of a CBT-I smartphone application (Sleep Ninja®) on insomnia symptoms in children. BMC Psychiatry 2023; 23:684. [PMID: 37730577 PMCID: PMC10510253 DOI: 10.1186/s12888-023-05185-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/17/2023] [Accepted: 09/12/2023] [Indexed: 09/22/2023] Open
Abstract
BACKGROUND Sleep is necessary for healthy development and mental wellbeing. Despite this, many children do not get the recommended duration of sleep each night, and many experience sleep problems. Although treatable, existing interventions for sleep disturbance are time-consuming, burdensome for families, and focus on providing behavioural strategies to parents rather than upskilling children directly. To address this gap, we modified Sleep Ninja®, an evidence-based cognitive behavioural therapy for insomnia (CBT-I) smartphone app for adolescent sleep disturbance, to be appropriate for 10 to 12 year olds. Here, we describe the protocol for a randomised controlled trial to evaluate the effect of Sleep Ninja on insomnia and other outcomes, including depression, anxiety, sleep quality, and daytime sleepiness, and explore effects on the emergence of Major Depressive Disorder (MDD), compared to an active control group. METHODS We aim to recruit 214 children aged 10 to 12 years old experiencing disturbed sleep. Participants will be screened for inclusion, complete the baseline assessment, and then be randomly allocated to receive Sleep Ninja, or digital psychoeducation flyers (active control) for 6-weeks. The primary outcome, insomnia symptoms, along with depression, anxiety, sleep quality, and daytime sleepiness will be assessed at 6-weeks (primary endpoint), 3-months, and 9-months post-baseline (secondary and tertiary endpoints, respectively). A mixed model repeated measures analytic approach will be used to conduct intention-to-treat analyses to determine whether reductions in insomnia and secondary outcomes are greater for those receiving Sleep Ninja relative to the control condition at the primary and secondary endpoints. The difference in relative risk for MDD onset will be explored at 9-months and compared between conditions. DISCUSSION This is the first clinical trial examining the effects of a CBT-I smartphone app in children experiencing sleep disturbance. Results will provide empirical evidence about the effects of Sleep Ninja on insomnia and other mental health outcomes. TRIAL REGISTRATION Australian New Zealand Clinical Trials Registry (ACTRN12623000587606). UNIVERSAL TRIAL NUMBER U1111-1294-4167.
Collapse
Affiliation(s)
- M Subotic-Kerry
- Black Dog Institute, University of New South Wales, Sydney, NSW, Australia
| | - A Werner-Seidler
- Black Dog Institute and School of Psychology, University of New South Wales, Sydney, NSW, Australia
| | - B Corkish
- Black Dog Institute, University of New South Wales, Sydney, NSW, Australia
| | - P J Batterham
- Centre for Mental Health Research, Australian National University, Canberra, Australia
| | - G Sicouri
- Black Dog Institute and School of Psychology, University of New South Wales, Sydney, NSW, Australia
| | - J Hudson
- Black Dog Institute and School of Psychology, University of New South Wales, Sydney, NSW, Australia
| | - H Christensen
- Faculty of Medicine and Health, University of New South Wales, Sydney, NSW, Australia
| | - B O'Dea
- Black Dog Institute, University of New South Wales, Sydney, NSW, Australia
| | - S H Li
- Black Dog Institute and School of Psychology, University of New South Wales, Sydney, NSW, Australia.
| |
Collapse
|
2
|
Gibbs V, Hudson J, Pellicano E. The Extent and Nature of Autistic People's Violence Experiences During Adulthood: A Cross-sectional Study of Victimisation. J Autism Dev Disord 2023; 53:3509-3524. [PMID: 35821545 PMCID: PMC10465381 DOI: 10.1007/s10803-022-05647-3] [Citation(s) in RCA: 5] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/10/2022] [Indexed: 10/17/2022]
Abstract
This study investigated the extent and nature of violence experiences reported by autistic adults. Autistic (n = 118) and non-autistic (n = 110) adults completed a questionnaire about their experiences of sexual harassment, stalking and harassment, sexual violence and physical violence since the age of 15. Autistic adults reported higher rates of all violence types, multiple forms of violence and repeated instances of the same type of violence. Typical gender differences in the patterns of violence (more physical violence reported by men and more sexual violence reported by women) were apparent in the non-autistic but not the autistic group. Findings add to the limited research in this area and highlight the need to identify risk and protective factors. Policy and practice implications are also discussed.
Collapse
Affiliation(s)
- Vicki Gibbs
- Macquarie School of Education, Macquarie University, Sydney, Australia.
| | | | | |
Collapse
|
3
|
Hancock A, Hutton D, Roberts D, Whiteside L, Golby C, Eccles CL, Turtle L, McGinn S, Hooton R, Fillingham E, Hudson J, Maguire M, Mackay R. Barriers and facilitators to conducting radiotherapy clinical trials: Findings from a UK survey. Radiography (Lond) 2023; 29:369-378. [PMID: 36758382 DOI: 10.1016/j.radi.2023.01.001] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2022] [Revised: 12/30/2022] [Accepted: 01/03/2023] [Indexed: 02/10/2023]
Abstract
INTRODUCTION As an essential component of service delivery, radiotherapy clinical trials were championed within the NHS England service specifications. A call for a 15% increase in research and clinical trial activity, alongside a demand for equity of access for patients with cancer subsequently ensued. National understanding of current radiotherapy clinical trials operational practices is absent, but essential to help establish the current provision required to support the development of a strategic plan for implementation of NHS England's specifications. METHODS A cross-sectional survey was developed by a multi-disciplinary team and distributed to therapeutic radiography clinical trial leads across the UK to ascertain the current provision of radiotherapy clinical trials only, including workforce resources and the trials management processes to establish a benchmark and identify potential barriers, enablers, and opportunities to increase access to clinical trials. RESULTS Thirty-two complete responses were obtained equating to 49% of the total UK NHS departments and 74% of those departments invited. Four key findings were identified: 1) research strategy and systems, 2) participation and activity in radiotherapy clinical trials, 3) access to clinical trials at alternative departments and 4) facilitators & barriers. Overarchingly a lack of radiotherapy clinical trials strategy or supported processes were apparent across the UK, aggravating existing barriers to trial activity. CONCLUSION It is essential for radiotherapy clinical trials to be embedded in to departmental and Trust strategy, this will help to ensure the processes and resources required for trial delivery are not only in place, but also recognised as imperative and important for patients with cancer as radiotherapy treatment delivery. IMPLICATIONS FOR PRACTICE Failure to address the barriers or build upon the facilitators may result in UK radiotherapy departments facing challenges in achieving the 15% increase in radiotherapy clinical trial activity.
Collapse
Affiliation(s)
- A Hancock
- University of Exeter, UK; Weston Park Cancer Centre, UK.
| | - D Hutton
- Northwest Radiotherapy Operational Delivery Network, UK; University of Liverpool, UK
| | | | | | | | - C L Eccles
- The Christie NHS FT, UK; University of Manchester, UK
| | - L Turtle
- The Clatterbridge Cancer Centre NHS FT, UK
| | - S McGinn
- The Clatterbridge Cancer Centre NHS FT, UK
| | - R Hooton
- The Clatterbridge Cancer Centre NHS FT, UK
| | | | - J Hudson
- Lancashire Teaching Hospitals, UK
| | - M Maguire
- The Clatterbridge Cancer Centre NHS FT, UK
| | - R Mackay
- The Christie NHS FT, UK; University of Manchester, UK
| |
Collapse
|
4
|
Le LKD, Chatterton ML, Rapee RM, Fitzpatrick S, Bussey K, Hudson J, Hunt C, Cross D, Magnus A, Mihalopoulos C. Burden and preference-based quality of life associated with bullying in children. Eur Child Adolesc Psychiatry 2023; 32:53-62. [PMID: 34046746 DOI: 10.1007/s00787-021-01807-5] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/02/2020] [Accepted: 05/17/2021] [Indexed: 11/24/2022]
Abstract
The objectives of this study are to assess the association between childhood bullying and preference-based health-related quality of life (QoL) in Australian school children and their parents and estimate quality-adjusted life years (QALYs) associated with bullying chronicity. Children aged 8-10 years completed the child health utilities (CHU-9D), while parents completed the Australian quality of life (AQoL-8D). Children were grouped into four categories of bullying involvement (no bullying, victim, perpetrator, or both perpetrator and victim) based on the Revised Olweus Bully/Victim Questionnaire. Parental data were compared across two bullying involvement groups (bullying vs. no bullying). QALYs were calculated for children over two years and comparisons made based on the number of assessments where bullying was reported (baseline, 1- and 2-year follow up). Children who were involved in bullying (victims and/or perpetrators) reported statistically significantly lower mean utility scores compared to children who were not involved in bullying. Parents whose child was involved in bullying had significantly lower mean utility scores compared to parents of children not involved with bullying. There appeared to be a dose-response relationship, with higher QALY losses associated with increasing frequency of reported bullying. Bullying among Australian school children was associated with significantly lower preference-based QoL for themselves and their parents. This study also confirmed the significant burden of disease for bullying among children measured by an incremental decrease in QALY with an increasing chronicity of bullying over time.
Collapse
Affiliation(s)
- Long Khanh-Dao Le
- Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Deakin University, Geelong, VIC, Australia.
| | - Mary Lou Chatterton
- Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Deakin University, Geelong, VIC, Australia
| | - Ronald M Rapee
- Department of Psychology, Centre for Emotional Health, Macquarie University, Sydney, Australia
| | - Sally Fitzpatrick
- Department of Psychology, Centre for Emotional Health, Macquarie University, Sydney, Australia
| | - Kay Bussey
- Department of Psychology, Centre for Emotional Health, Macquarie University, Sydney, Australia
| | - Jennie Hudson
- Department of Psychology, Centre for Emotional Health, Macquarie University, Sydney, Australia
| | - Caroline Hunt
- School of Psychology, University of Sydney, Sydney, NSW, 2006, Australia
| | - Donna Cross
- Telethon Kids Institute, The University of Western Australia, Subiaco, WA, Australia.,Edith Cowan University, Joondalup, WA, Australia
| | - Anne Magnus
- Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Deakin University, Geelong, VIC, Australia
| | - Cathrine Mihalopoulos
- Deakin Health Economics, Institute for Health Transformation, School of Health and Social Development, Deakin University, Geelong, VIC, Australia
| |
Collapse
|
5
|
Teuwen LA, Young J, Davies A, Hudson J, Bourlon de los Rios M, Prenen H, Segelov E. 432P Representation of countries and gender in abstracts at the 2022 American Society of Clinical Oncology Annual Scientific Meeting (ASCO ASM). Ann Oncol 2022. [DOI: 10.1016/j.annonc.2022.10.463] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/07/2022] Open
|
6
|
Hudson J, Bourne SD, Seebens H, Chapman MA, Rius M. The reconstruction of invasion histories with genomic data in light of differing levels of anthropogenic transport. Philos Trans R Soc Lond B Biol Sci 2022; 377:20210023. [PMID: 35067090 PMCID: PMC8784929 DOI: 10.1098/rstb.2021.0023] [Citation(s) in RCA: 7] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Unravelling the history of range shifts is key for understanding past, current and future species distributions. Anthropogenic transport of species alters natural dispersal patterns and directly affects population connectivity. Studies have suggested that high levels of anthropogenic transport homogenize patterns of genetic differentiation and blur colonization pathways. However, empirical evidence of these effects remains elusive. We compared two range-shifting species (Microcosmus squamiger and Ciona robusta) to examine how anthropogenic transport affects our ability to reconstruct colonization pathways using genomic data. We first investigated shipping networks from the 18th century onwards, cross-referencing these with regions where the species have records to infer how each species has potentially been affected by different levels of anthropogenic transport. We then genotyped thousands of single-nucleotide polymorphisms from 280 M. squamiger and 190 C. robusta individuals collected across their extensive species' ranges and reconstructed colonization pathways. Differing levels of anthropogenic transport did not preclude the elucidation of population structure, though specific inferences of colonization pathways were difficult to discern in some of the considered scenario sets. We conclude that genomic data in combination with information of underlying introduction drivers provide key insights into the historic spread of range-shifting species. This article is part of the theme issue ‘Species’ ranges in the face of changing environments (part I)’.
Collapse
Affiliation(s)
- J Hudson
- School of Ocean and Earth Science, University of Southampton, National Oceanography Centre, European Way, Southampton SO14 3ZH, UK
| | - S D Bourne
- School of Ocean and Earth Science, University of Southampton, National Oceanography Centre, European Way, Southampton SO14 3ZH, UK
| | - H Seebens
- Senckenberg Biodiversity and Climate Research Centre, Senckenberganlage 25, 60325 Frankfurt, Germany
| | - M A Chapman
- Department of Biological Sciences, University of Southampton, Life Sciences Building 85, Highfield Campus, Southampton SO17 1BJ, UK
| | - M Rius
- School of Ocean and Earth Science, University of Southampton, National Oceanography Centre, European Way, Southampton SO14 3ZH, UK.,Department of Zoology, Centre for Ecological Genomics and Wildlife Conservation, University of Johannesburg, Auckland Park 2006, South Africa.,Centre for Advanced Studies of Blanes (CEAB, CSIC), Accés a la Cala Sant Francesc 14, Blanes 17300, Spain
| |
Collapse
|
7
|
Voges H, Parker B, Quaife-Ryan G, Friedmand C, Palpant N, Del Monte-Nieto G, Elliott D, Mills R, Porrello E, Hudson J. Development of a Vascularised Cardiac Organoid Platform Reveals a Regulatory Role for Extracellular Matrix Environment on Muscle Functionality. Heart Lung Circ 2022. [DOI: 10.1016/j.hlc.2022.06.536] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
|
8
|
Aliaj E, Hudson J, Roman C, Clancy J. 588: Insights into and input on genetic-based therapies and clinical trials by the cystic fibrosis community. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)02011-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
9
|
Hudson J, Green J, Clancy J, Roman C. 322: Communities of color provide insights about engagement barriers. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01746-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
10
|
Keogh M, Topf A, Marini-Bettolo C, Hudson J, Colomer J, Nascimento A, Oliver M, Alvarez R, Durmus H, Nafissi S, Bastian A, Vissing J, Witting N, Diaz-Manera J, Straub V. OTHER NMDs. Neuromuscul Disord 2021. [DOI: 10.1016/j.nmd.2021.07.381] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
11
|
Redd M, Scheuer S, Saez N, Yoshikawa Y, Chiu H, Gao L, Hicks M, Villanueva J, Cuellar-Partida G, Peart J, See Hoe L, Chen X, Sun Y, Suen J, Hatch R, Rollo B, Alzubaidi M, Maljevic S, Quaife-Ryan G, Hudson J, Porrello E, White M, Cordwell S, Fraser J, Petrou S, Reichelt M, Thomas W, King G, Macdonald P, Palpant N. Genetic and Pharmacological Studies Reveal Acid Sensing Ion Channel 1a as a Novel Therapeutic Target Against Cardiac Ischaemia-Reperfusion Injury. Heart Lung Circ 2021. [DOI: 10.1016/j.hlc.2021.06.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
12
|
Ross S, Holliday M, Lim S, Mangala M, Perry M, Gray B, Fraser S, Hill A, Hudson J, Semsarian C. Functional Analysis of a Novel Heterozygous Variant in CASQ2 as a Distinct Cause of Catecholaminergic Polymorphic Ventricular Tachycardia. Heart Lung Circ 2021. [DOI: 10.1016/j.hlc.2021.06.016] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
13
|
Creswell C, Waite P, Hudson J. Practitioner Review: Anxiety disorders in children and young people - assessment and treatment. J Child Psychol Psychiatry 2020; 61:628-643. [PMID: 31960440 DOI: 10.1111/jcpp.13186] [Citation(s) in RCA: 49] [Impact Index Per Article: 12.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/06/2019] [Revised: 11/18/2019] [Accepted: 12/02/2019] [Indexed: 01/04/2023]
Abstract
Despite significant advancements in our knowledge of anxiety disorders in children and adolescents, they continue to be underrecognised and undertreated. It is critical that these disorders are taken seriously in children and young people as they are highly prevalent, have a negative impact on educational, social and health functioning, create a risk of ongoing anxiety and other mental health disorders across the life span and are associated with substantial economic burden. Yet very few children with anxiety disorders access evidence-based treatments, and there is an urgent need for widespread implementation of effective interventions. This review aimed to provide an overview of recent research developments that will be relevant to clinicians and policymakers, particularly focusing on the development and maintenance of child anxiety disorders and considerations for assessment and treatment. Given the critical need to increase access to effective support, we hope this review will contribute to driving forward a step change in treatment delivery for children and young people with anxiety disorders and their families.
Collapse
Affiliation(s)
- Cathy Creswell
- Department of Experimental Psychology, University of Oxford, Oxford, UK.,Department of Psychiatry, University of Oxford, Oxford, UK
| | - Polly Waite
- Department of Experimental Psychology, University of Oxford, Oxford, UK.,Department of Psychiatry, University of Oxford, Oxford, UK.,School of Psychology and Clinical Language Sciences, University of Reading, Reading, UK
| | - Jennie Hudson
- Centre for Emotional Health, Macquarie University, Sydney, NSW, Australia
| |
Collapse
|
14
|
Hamid A, Willan T, Hudson J. Double rooted lateral? Br Dent J 2020; 228:662-663. [DOI: 10.1038/s41415-020-1602-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
|
15
|
Fyyaz S, Hudson J, Olabintan O, Katsigris A, David S, Plein S, Alfakih K. P1589 Yield of invasive coronary angiography following the UK NICE 2016 guideline expansion of CT coronary angiography. Eur Heart J Cardiovasc Imaging 2020. [DOI: 10.1093/ehjci/jez319.1009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
The UK National Institute of Health and Care Excellence (NICE) updated chest pain guidelines in 2016 and recommended CT coronary angiography (CTCA) as the first line investigation for all patients presenting with new stable chest pain and the removal of the pre-test probability risk scoring. There is a concern that using CTCA in populations with higher likelihood of coronary artery disease (CAD), can lead to higher rates of downstream testing with invasive coronary angiography (ICA). We implemented the NICE 2016 guideline and audited the downstream testing after CTCA. We also evaluated the performance of the ESC risk score (ESC RS).
Methods
We undertook a retrospective search of the radiology database from January 2017 to June 2018. CTCA reported CAD degree of stenosis as normal/minimal stenosis, mild (30-50%), moderate (50-70%), or severe (>70%).
Results
In total 652 patients underwent CTCA (mean age 55 yrs; 330 male). 92 patients were found to have moderate or severe stenosis. 69 of them were referred directly to ICA, with 63 undergoing ICA and confirming severe CAD in 40 patients, a yield of 63%. 18 patients with moderate stenosis were referred for stress echo (SE) with one positive result. In total 35 patients went on to be revascularised.
62 patients were found to have mild stenosis. The majority of patients (n = 462) had normal/minimal stenosis. There were 36 inconclusive studies.
The ESC RS was calculated retrospectively with the following results:
70 patients had an ESC RS <15% and 2 (3%) were found to have moderate stenosis. 427 patients had an ESC RS 15-50%; 17 (4%) had severe stenosis and 32 (8%) moderate stenosis. 149 patients had an ESC RS 50-85%; 17 (11%) were found to have severe stenosis and 23 (15%) moderate stenosis. Lastly 2 patients had an ESC RS >85% and one had moderate stenosis.
Conclusions
Our results demonstrate that CTCA is an effective first line test for most patients with new stable chest pain as the majority were found to have normal/minimal disease. In the patients that went on to have ICA, CTCA had a relatively high yield of detecting severe CAD (63%). This was achieved with some use of SE as a gatekeeper to ICA, particularly in patients with moderate CTCA stenosis. SE should be used more after CTCA in patients with moderate stenosis, as a gatekeeper to ICA.
The ESC RS was predictive of significant CAD but overestimated the likelihood of CAD.
Abstract P1589 Figure. Severe CTCA stenosis of the LAD
Collapse
Affiliation(s)
- S Fyyaz
- Lewisham & Greenwich NHS Trust, Department of Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| | - J Hudson
- Lewisham & Greenwich NHS Trust, Department of Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| | - O Olabintan
- Lewisham & Greenwich NHS Trust, Department of Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| | - A Katsigris
- Lewisham Healthcare NHS Trust, Department of Radiology, London, United Kingdom of Great Britain & Northern Ireland
| | - S David
- Lewisham Healthcare NHS Trust, Department of Radiology, London, United Kingdom of Great Britain & Northern Ireland
| | - S Plein
- University of Leeds, Multidisciplinary Cardiovascular Research Centre & Division of Biomedical Imaging, Leeds, United Kingdom of Great Britain & Northern Ireland
| | - K Alfakih
- Lewisham & Greenwich NHS Trust, Department of Cardiology, London, United Kingdom of Great Britain & Northern Ireland
| |
Collapse
|
16
|
Batho C, Hudson J, Mills R. 155 Protein Prenylation is Essential for Cardiomyocyte Proliferation. Heart Lung Circ 2020. [DOI: 10.1016/j.hlc.2020.09.162] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
17
|
Alibhai S, Jung P, Rowbottom L, Yokom D, Syed A, Alam Z, Malik U, Yeung L, Ayala A, Reka R, Puts M, Hudson J. DELIRIUM INCIDENCE, PREVENTION, AND TREATMENT IN OLDER ADULTS RECEIVING CHEMOTHERAPY: AN UPDATED SCOPING REVIEW AND META-ANALYSIS. J Geriatr Oncol 2019. [DOI: 10.1016/s1879-4068(19)31285-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
18
|
Nagareddy P, Sreejit G, Abdel-Latif A, Athmanathan B, Annabathula R, Dhyani A, Noothi S, Quaife-Ryan G, Hudson J, Smyth S, Porrello E, Murphy A. Nlrp3 Inflammasome-Primed Neutrophils Return To The Bone Marrow To Propagate Granulopoiesis Following Myocardial Injury. Atherosclerosis 2019. [DOI: 10.1016/j.atherosclerosis.2019.06.063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
19
|
Hudson J, Males JR, Kerr JH. Introducing a basic psychological performance demand model for sport and organisations. Coaching: An International Journal of Theory, Research and Practice 2019. [DOI: 10.1080/17521882.2019.1574848] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Affiliation(s)
- J. Hudson
- School of Sport and Exercise Sciences, Swansea University, Swansea, UK
| | | | - J. H. Kerr
- School of Kinesiology, University of British Columbia, Vancouver, Canada
| |
Collapse
|
20
|
Bourne SD, Hudson J, Holman LE, Rius M. Marine Invasion Genomics: Revealing Ecological and Evolutionary Consequences of Biological Invasions. ACTA ACUST UNITED AC 2018. [DOI: 10.1007/13836_2018_21] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022]
|
21
|
Huckins LM, Hatzikotoulas K, Southam L, Thornton LM, Steinberg J, Aguilera-McKay F, Treasure J, Schmidt U, Gunasinghe C, Romero A, Curtis C, Rhodes D, Moens J, Kalsi G, Dempster D, Leung R, Keohane A, Burghardt R, Ehrlich S, Hebebrand J, Hinney A, Ludolph A, Walton E, Deloukas P, Hofman A, Palotie A, Palta P, van Rooij FJA, Stirrups K, Adan R, Boni C, Cone R, Dedoussis G, van Furth E, Gonidakis F, Gorwood P, Hudson J, Kaprio J, Kas M, Keski-Rahonen A, Kiezebrink K, Knudsen GP, Slof-Op 't Landt MCT, Maj M, Monteleone AM, Monteleone P, Raevuori AH, Reichborn-Kjennerud T, Tozzi F, Tsitsika A, van Elburg A, Collier DA, Sullivan PF, Breen G, Bulik CM, Zeggini E. Investigation of common, low-frequency and rare genome-wide variation in anorexia nervosa. Mol Psychiatry 2018; 23:1169-1180. [PMID: 29155802 PMCID: PMC5828108 DOI: 10.1038/mp.2017.88] [Citation(s) in RCA: 27] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/03/2016] [Revised: 02/16/2017] [Accepted: 02/17/2017] [Indexed: 12/12/2022]
Abstract
Anorexia nervosa (AN) is a complex neuropsychiatric disorder presenting with dangerously low body weight, and a deep and persistent fear of gaining weight. To date, only one genome-wide significant locus associated with AN has been identified. We performed an exome-chip based genome-wide association studies (GWAS) in 2158 cases from nine populations of European origin and 15 485 ancestrally matched controls. Unlike previous studies, this GWAS also probed association in low-frequency and rare variants. Sixteen independent variants were taken forward for in silico and de novo replication (11 common and 5 rare). No findings reached genome-wide significance. Two notable common variants were identified: rs10791286, an intronic variant in OPCML (P=9.89 × 10-6), and rs7700147, an intergenic variant (P=2.93 × 10-5). No low-frequency variant associations were identified at genome-wide significance, although the study was well-powered to detect low-frequency variants with large effect sizes, suggesting that there may be no AN loci in this genomic search space with large effect sizes.
Collapse
Affiliation(s)
- L M Huckins
- Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
- Division of Psychiatric Genomics, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - K Hatzikotoulas
- Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
| | - L Southam
- Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
| | - L M Thornton
- Department of Psychiatry and Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
| | - J Steinberg
- Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
| | - F Aguilera-McKay
- Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
| | - J Treasure
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - U Schmidt
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - C Gunasinghe
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR BRC SLaM BioResource for Mental Health, SGDP Centre & Centre for Neuroimaging Sciences, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - A Romero
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR BRC SLaM BioResource for Mental Health, SGDP Centre & Centre for Neuroimaging Sciences, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - C Curtis
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR BRC SLaM BioResource for Mental Health, SGDP Centre & Centre for Neuroimaging Sciences, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - D Rhodes
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR BRC SLaM BioResource for Mental Health, SGDP Centre & Centre for Neuroimaging Sciences, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - J Moens
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR BRC SLaM BioResource for Mental Health, SGDP Centre & Centre for Neuroimaging Sciences, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - G Kalsi
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR BRC SLaM BioResource for Mental Health, SGDP Centre & Centre for Neuroimaging Sciences, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - D Dempster
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR BRC SLaM BioResource for Mental Health, SGDP Centre & Centre for Neuroimaging Sciences, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - R Leung
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR BRC SLaM BioResource for Mental Health, SGDP Centre & Centre for Neuroimaging Sciences, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - A Keohane
- Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
- NIHR BRC SLaM BioResource for Mental Health, SGDP Centre & Centre for Neuroimaging Sciences, Section of Eating Disorders, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK
| | - R Burghardt
- Klinik für Kinder- und Jugendpsychiatrie, Psychotherapie und Psychosomatik Klinikum Frankfurt, Frankfurt, Germany
| | - S Ehrlich
- Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Dresden, Germany
- Eating Disorders Research and Treatment Center, Department of Child and Adolescent Psychiatry, Faculty of Medicine, TU Dresden, Dresden, Germany
| | - J Hebebrand
- Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
| | - A Hinney
- Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
| | - A Ludolph
- Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Neuherberg, Germany
| | - E Walton
- Division of Psychological & Social Medicine and Developmental Neurosciences, Technische Universität Dresden, Faculty of Medicine, University Hospital C.G. Carus, Dresden, Germany
- Department of Psychology, Georgia State University, Atlanta, GA, USA
| | - P Deloukas
- Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
| | - A Hofman
- Erasmus University Medical Center, Rotterdam, The Netherlands
| | - A Palotie
- Center for Human Genome Research at the Massachusetts General Hospital, Boston, MA, USA
- Department of Public Health & Institute for Molecular Medicine FIMM, University of Helsinki, Helsinki, Finland
| | - P Palta
- Department of Public Health & Institute for Molecular Medicine FIMM, University of Helsinki, Helsinki, Finland
| | - F J A van Rooij
- Erasmus University Medical Center, Rotterdam, The Netherlands
| | - K Stirrups
- Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
| | - R Adan
- Brain Center Rudolf Magnus, Department of Neuroscience and Pharmacology, University Medical Center Utrecht, Utrecht, The Netherlands
| | - C Boni
- INSERM U984, Centre of Psychiatry and Neuroscience, Paris, France
| | - R Cone
- Mary Sue Coleman Director, Life Sciences Institute, Professor of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA
| | - G Dedoussis
- Department of Dietetics-Nutrition, Harokopio University, Athens, Greece
| | - E van Furth
- Rivierduinen Eating Disorders Ursula, Leiden, Zuid-Holland, The Netherlands
| | - F Gonidakis
- Eating Disorders Unit, 1st Department of Psychiatry, National and Kapodistrian University of Athens, Medical School, Athens, Greece
| | - P Gorwood
- INSERM U984, Centre of Psychiatry and Neuroscience, Paris, France
| | - J Hudson
- Department of Psychiatry, McLean Hospital/Harvard Medical School, Belmont, MA, USA
| | - J Kaprio
- Department of Public Health & Institute for Molecular Medicine FIMM, University of Helsinki, Helsinki, Finland
| | - M Kas
- Groningen Institute for Evolutionary Life Sciences, University of Groningen, Groningen, The Netherlands
| | - A Keski-Rahonen
- Department of Public Health, Clinicum, University of Helsinki, Helsinki, Finland
| | - K Kiezebrink
- Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK
| | - G-P Knudsen
- Health Data and Digitalisation, Norwegian Institute of Public Health, Oslo, Norway
| | | | - M Maj
- Department of Psychiatry, University of Naples SUN, Naples, Italy
| | - A M Monteleone
- Department of Psychiatry, University of Naples SUN, Naples, Italy
| | - P Monteleone
- Department of Medicine and Surgery, Section of Neurosciences, University of Salerno, Salerno, Italy
| | - A H Raevuori
- Department of Public Health, Clinicum, University of Helsinki, Helsinki, Finland
| | - T Reichborn-Kjennerud
- Department of Genetics, Environment and Mental Health, Norwegian Institute of Public Health, Oslo, Norway
| | - F Tozzi
- eHealth Lab-Computer Science Department, University of Cyprus, Nicosia, Cyprus
| | - A Tsitsika
- Adolescent Health Unit (A.H.U.), 2nd Department of Pediatrics – Medical School, University of Athens "P. & A. Kyriakou" Children's Hospital, Athens, Greece
| | - A van Elburg
- Center for Eating Disorders Rintveld, University of Utrecht, Utrecht, The Netherlands
| | - D A Collier
- Eli Lilly and Company, Erl Wood Manor, Windlesham, UK
| | - P F Sullivan
- Departments of Genetics and Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- Department of Medical Epidemiology and Biostatistics, Karolinksa Institutet, Stockholm, Sweden
| | - G Breen
- Social Genetic and Developmental Psychiatry, King's College London, London, UK
| | - C M Bulik
- Department of Psychiatry and Nutrition, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
- Department of Medical Epidemiology and Biostatistics, Karolinksa Institutet, Stockholm, Sweden
| | - E Zeggini
- Department of Human Genetics, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, UK
| |
Collapse
|
22
|
Pope H, Kanayama G, Jane's A, Hudson J, Brennan B, Jensen E, Kaufman M. Long-term anabolic-androgenic steroid (AAS) Use: A possible new risk factor for early dementia. J Neurol Sci 2017. [DOI: 10.1016/j.jns.2017.08.2179] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
23
|
Metcalf R, Mohan S, Hilton S, Pierce J, Hudson J, Betts G, Chaturvedi A, Homer J, Leong H, Schofield P, Rothwell D, Brady G, Dive C. The application of liquid biopsies in metastatic salivary gland cancer to identify candidate therapeutic targets. Ann Oncol 2017. [DOI: 10.1093/annonc/mdx508.016] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
24
|
Affiliation(s)
- J.P. Krasznai
- Ontario Hydro Research Division 800 Kipling Avenue Toronto, M8Z 5S4 Ontario, CANADA
| | - V.S. Chew
- Ontario Hydro Research Division 800 Kipling Avenue Toronto, M8Z 5S4 Ontario, CANADA
| | - J. Hudson
- Darlington Generating Station Box 4000 Bowmanville L1C 3W2 Ontario, CANADA
| |
Collapse
|
25
|
Males JR, Hudson J, Kerr JH. Application of an innovative performance demand model with canoe slalom athletes and their coach. Journal of Sport Psychology in Action 2017. [DOI: 10.1080/21520704.2017.1326429] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Affiliation(s)
| | | | - J. H. Kerr
- University of British Columbia, Vancouver, British Columbia, Canada
| |
Collapse
|
26
|
Shalhoub J, Norrie J, Baker C, Bradbury A, Dhillon K, Everington T, Gohel M, Hamady Z, Heatley F, Hudson J, Hunt B, Lawton R, Stansby G, Stephens-Boal A, Toh S, Warwick D, Davies A. Graduated Compression Stockings as an Adjunct to Low Dose Low Molecular Weight Heparin in Venous Thromboembolism Prevention in Surgery: A Multicentre Randomised Controlled Trial. Eur J Vasc Endovasc Surg 2017; 53:880-885. [DOI: 10.1016/j.ejvs.2017.02.013] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/07/2016] [Accepted: 02/08/2017] [Indexed: 11/28/2022]
|
27
|
Harris E, Töpf A, Hudson J, Barresi R, Bushby K, Lochmüller H, Straub V. Myofibrillar myopathy phenotype due to recessive mutations in MEGF10. Neuromuscul Disord 2017. [DOI: 10.1016/s0960-8966(17)30242-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
28
|
Vivien C, Pichol-Thievend C, Bower N, Hogan B, Hudson J, Francois M, Porrello E. Role of Lymphangiogenesis in Zebrafish Cardiac Regeneration. Heart Lung Circ 2017. [DOI: 10.1016/j.hlc.2017.06.235] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
29
|
Hudson J, Mercer S. The Role 2 Afloat custodian. J R Nav Med Serv 2017; 103:14-16. [PMID: 30088732] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
The Role 2 Afloat (R2A) capability is now firmly established on several maritime platforms using the 370 Module (afloat) equipment. This year has seen the appointment on board ships that support R2A of a new full-time role, the Medical Module Manager (MMM), who is responsible for the equipment on board. This article outlines the new role.
Collapse
|
30
|
Ma Z, Quaife-Ryan G, Lynch J, McLellan C, Mills R, Phipps S, Cooper-White J, Hudson J, Porrello E. Intramyocardial Delivery of miR-29a Improves Cardiac Function and Prevents Pathological Remodelling Following Myocardial Infarction. Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.182] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
31
|
Ryan QG, Ma Z, Sim C, Ramialison M, Thomas W, Hudson J, Porrello E. Cellular Transcriptomic Analysis of Multiple Cardiac Lineages During Heart Development and Regeneration. Heart Lung Circ 2016. [DOI: 10.1016/j.hlc.2016.06.079] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
32
|
Preethish-Kumar V, Pogoryelova O, Polavarapu K, Gayathri N, Seena V, Hudson J, Nishino I, Prasad C, Lochmüller H, Nalini A. Beevor's sign: a potential clinical marker for GNE myopathy. Eur J Neurol 2016; 23:e46-8. [PMID: 27431025 DOI: 10.1111/ene.13041] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2015] [Accepted: 04/04/2016] [Indexed: 11/28/2022]
Affiliation(s)
- V Preethish-Kumar
- Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bengaluru, India
| | - O Pogoryelova
- John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - K Polavarapu
- Clinical Neurosciences, National Institute of Mental Health and Neurosciences, Bengaluru, India
| | - N Gayathri
- Neuropathology, National Institute of Mental Health and Neurosciences, Bengaluru, India
| | - V Seena
- Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India
| | - J Hudson
- Northern Genetics Service, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - I Nishino
- Department of Neuromuscular Research, National Institute of Neuroscience, National Centre of Neurology and Psychiatry (NCNP), Tokyo, Japan
| | - C Prasad
- Neuro Imaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bengaluru, India
| | - H Lochmüller
- John Walton Muscular Dystrophy Research Centre, MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - A Nalini
- Department of Neurology, National Institute of Mental Health and Neurosciences, Bengaluru, India
| |
Collapse
|
33
|
Figueroa-Bonaparte S, Hudson J, Barresi R, Polvikoski T, Williams T, Töpf A, Harris E, Hilton-Jones D, Petty R, Willis TA, Longman C, Dougan CF, Parton MJ, Hanna MG, Quinlivan R, Farrugia ME, Guglieri M, Bushby K, Straub V, Lochmüller H, Evangelista T. Mutational spectrum and phenotypic variability of VCP-related neurological disease in the UK. J Neurol Neurosurg Psychiatry 2016; 87:680-1. [PMID: 26105173 PMCID: PMC4893144 DOI: 10.1136/jnnp-2015-310362] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/12/2015] [Revised: 04/16/2015] [Accepted: 05/05/2015] [Indexed: 11/04/2022]
Affiliation(s)
- S Figueroa-Bonaparte
- Department of Neurology, Hospital de la Santa Creu i Sant Pau, and Universitat Autónoma de Barcelona, Barcelona, Spain
| | - J Hudson
- The John Walton Muscular Dystrophy Research Centre and MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - R Barresi
- The John Walton Muscular Dystrophy Research Centre and MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
- Rare Diseases Advisory Group Service for Neuromuscular Diseases, Muscle Immunoanalysis Unit, Dental Hospital, Newcastle upon Tyne, UK
| | - T Polvikoski
- Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK
| | - T Williams
- Department of Neurology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
| | - A Töpf
- The John Walton Muscular Dystrophy Research Centre and MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - E Harris
- The John Walton Research Centre and MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - D Hilton-Jones
- Department of Neurology, John Radcliffe Hospital, Oxford, UK
| | - R Petty
- Department of Neurology, Southern General Hospital, Glasgow, UK
| | - T A Willis
- The Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry, UK
| | - C Longman
- West of Scotland Regional Genetics Service, Southern General Hospital, Glasgow, UK
| | - C F Dougan
- The Walton Centre for Neurology and Neurosurgery, Liverpool, UK
| | - M J Parton
- UCL MRC Centre for Neuromuscular Disease, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen- Square, London, UK
| | - M G Hanna
- MRC Centre for Neuromuscular Disease and National Hospital for Neurology and Neurosurgery, London, UK
| | - R Quinlivan
- UCL MRC Centre for Neuromuscular Disease, Institute of Neurology and National Hospital for Neurology and Neurosurgery, Queen- Square, London, UK
| | - M E Farrugia
- Department of Neurology, Southern General Hospital, Glasgow, UK
| | - M Guglieri
- The John Walton Muscular Dystrophy Research Centre and MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - K Bushby
- The John Walton Muscular Dystrophy Research Centre and MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - V Straub
- The John Walton Muscular Dystrophy Research Centre and MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - H Lochmüller
- The John Walton Muscular Dystrophy Research Centre and MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| | - T Evangelista
- The John Walton Muscular Dystrophy Research Centre and MRC Centre for Neuromuscular Diseases, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK
| |
Collapse
|
34
|
Willis T, Wood C, Hudson J, Polvikoski T, Barresi R, Lochmüller H, Bushby K, Straub V. Muscle hypertrophy as the presenting sign in a patient with a completeFHL1deletion. Clin Genet 2016; 90:166-70. [DOI: 10.1111/cge.12695] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/14/2015] [Revised: 11/02/2015] [Accepted: 11/12/2015] [Indexed: 12/19/2022]
Affiliation(s)
- T.A. Willis
- John Walton Muscular Dystrophy Research Centre; Institute of Genetic Medicine; Newcastle upon Tyne UK
| | - C.L. Wood
- John Walton Muscular Dystrophy Research Centre; Institute of Genetic Medicine; Newcastle upon Tyne UK
| | - J. Hudson
- John Walton Muscular Dystrophy Research Centre; Institute of Genetic Medicine; Newcastle upon Tyne UK
| | - T. Polvikoski
- Institute of Neuroscience; Newcastle University; Newcastle upon Tyne UK
| | - R. Barresi
- John Walton Muscular Dystrophy Research Centre; Institute of Genetic Medicine; Newcastle upon Tyne UK
- Rare Diseases Advisory Group Service for Neuromuscular Diseases; Muscle Immunoanalysis Unit; Newcastle upon Tyne UK
| | - H. Lochmüller
- John Walton Muscular Dystrophy Research Centre; Institute of Genetic Medicine; Newcastle upon Tyne UK
| | - K. Bushby
- John Walton Muscular Dystrophy Research Centre; Institute of Genetic Medicine; Newcastle upon Tyne UK
| | - V. Straub
- John Walton Muscular Dystrophy Research Centre; Institute of Genetic Medicine; Newcastle upon Tyne UK
| |
Collapse
|
35
|
Harris E, Hudson J, Marsh J, Marini Bettolo C, Neri M, Ferlini A, Bushby K, Lochmüller H, Straub V, Barresi R. A novel STIM1 mutation at p.340 causes tubular aggregate myopathy with miosis without additional features of Stormorken syndrome. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.369] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
36
|
Hudson J, Graham E, Charlton R, Guglieri M, Bushby K, Straub V, Barresi R. The importance of dosage analysis in dysferlinopathy. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.171] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
37
|
Sframeli M, Sarkozy A, Bertoli M, Astrea G, Hudson J, Scoto M, Mein R, Yau M, Phadke R, Feng L, Sewry C, Robb S, Manzur A, Messina S, Bushby K, Muntoni F. Congenital muscular dystrophies in the UK population: Update of clinical and molecular spectrum of patients diagnosed over a 12-year period. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.303] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
38
|
Evangelista T, Wood L, Pohlschmidt M, Longman C, Roberts M, Hilton-Jones D, Lunt P, Wills T, Orrell R, Norwood F, Williams M, Smith D, Hudson J, Lochmüller H. Pain and quality of life in the UK FSHD patient registry. Neuromuscul Disord 2015. [DOI: 10.1016/j.nmd.2015.06.108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
39
|
Barredo R, Foster H, Norina Weatherman M, Hudson J. Review of evidence on the effectiveness of whole body vibration on muscle strength and mass of adults 55 and older. Physiotherapy 2015. [DOI: 10.1016/j.physio.2015.03.255] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
40
|
Voges H, Mills R, Porrello E, Hudson J. An in vitro model of acute myocardial damage in human bioengineered heart muscle. Heart Lung Circ 2015. [DOI: 10.1016/j.hlc.2015.06.201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
41
|
|
42
|
Taylor A, Jarvis M, Hudson J. P54 Capillary electrophoresis – mass spectrometry for the forensic analysis of cathinone drugs and metabolites. Toxicologie Analytique et Clinique 2014. [DOI: 10.1016/s2352-0078(14)70115-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
43
|
Barresi R, Charlton R, Hudson J, Bushby K. P73 The national diagnostic and advisory service for limb-girdle muscular dystrophies in Newcastle. Neuromuscul Disord 2014. [DOI: 10.1016/s0960-8966(14)70089-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
44
|
Sarkozy A, Hicks D, Hudson J, Laval S, Barresi R, Guglieri M, Harris E, Straub V, Bushby K, Lochmuller H. P.5.9 Clinical and molecular analysis of a large cohort of patients with anoctaminopathy. Neuromuscul Disord 2013. [DOI: 10.1016/j.nmd.2013.06.461] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
45
|
Hudson J, Davison G, Robinson P. Psychophysiological and stress responses to competition in team sport coaches: an exploratory study. Scand J Med Sci Sports 2013; 23:e279-85. [PMID: 23662710 DOI: 10.1111/sms.12075] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/19/2013] [Indexed: 11/27/2022]
Abstract
Examinations of stress in coaches have mainly been qualitative and focused on chronic stressors. This exploratory study examined stress responses in coaches during competition, including psychological and physiological indices. Using reversal theory, we examined metamotivational state profiles during competition. Ten male team sport coaches (mean age 39.8 ± 13.12 years) reported levels of subjective stress, pleasant and unpleasant emotions, metamotivational state, and provided saliva samples, on a competition day: 15 min prior to the pre-match team talk; start of the match; end of the first half; start of the second half, and end of the match, then at equivalent times on a noncompetition day. Saliva samples were assayed for alpha-amylase activity. On competition day, alpha-amylase activity was significantly higher, as were subjective stress, arousal, and unpleasant emotions. Prior to and during active play, participants were mainly in the conformist, alloic (other-oriented), and mastery states, and at the end of the match, in the telic and sympathy states. Only 22 metamotivational state reversals were observed, mostly at the start and end of the match. The elevated levels of subjective stress, alpha-amylase activity, and unpleasant emotions suggest that educational programs may be useful for some coaches to manage psychological states during competition.
Collapse
Affiliation(s)
- J Hudson
- Department of Sport and Exercise Science, Institute of Human Sciences, Aberystwyth University, Penglais Campus, Aberystwyth, Ceredigion, UK
| | | | | |
Collapse
|
46
|
Narayanan R, Fu B, Payton A, Hudson J, Oliver R, Anderson S, Siddals K, White A, Ollier W, Heald A, Gibson J. IGF2 Gene Polymorphisms and IGF-II Concentration are Determinants of Longitudinal Weight Trends in Type 2 Diabetes. Exp Clin Endocrinol Diabetes 2013; 121:361-7. [DOI: 10.1055/s-0033-1345122] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
Affiliation(s)
| | - B. Fu
- School of Community-based Medicine
| | - A. Payton
- Centre for Integrated Genomic Medical Research
| | | | | | | | | | - A. White
- Endocrinology and Diabetes, Faculty of Medical, Human and Life Sciences, The University of Manchester, Manchester, United Kingdom
| | - W.E. Ollier
- Centre for Integrated Genomic Medical Research
| | | | | |
Collapse
|
47
|
Setnik B, Arora S, Drass M, Hudson J, Clemmer R, Meisner P, Pixton G, Sommerville K. A multicenter, 12-month, open-label, single-arm, safety study of oxycodone hydrochloride and naltrexone hydrochloride extended-release capsules (ALO-02) in patients with moderate to severe chronic non-cancer pain. The Journal of Pain 2013. [DOI: 10.1016/j.jpain.2013.01.654] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
48
|
Hudson J, Nguku SM, Sleiman J, Karlen W, Dumont GA, Petersen CL, Warriner CB, Ansermino JM. Usability testing of a prototype Phone Oximeter with healthcare providers in high- and low-medical resource environments. Anaesthesia 2012; 67:957-67. [PMID: 22861503 DOI: 10.1111/j.1365-2044.2012.07196.x] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
To increase the use of pulse oximetry by capitalise on the wide availability of mobile phones, we have designed, developed and evaluated a prototype pulse oximeter interfaced to a mobile phone. Usability of this Phone Oximeter was tested as part of a rapid prototyping process. Phase 1 of the study (20 subjects) was performed in Canada. Users performed 23 tasks, while thinking aloud. Time for completion of tasks and analysis of user response to a mobile phone usability questionnaire were used to evaluate usability. Five interface improvements were made to the prototype before evaluation in Phase 2 (15 subjects) in Uganda. The lack of previous pulse oximetry experience and mobile phone use increased median (IQR [range]) time taken to perform tasks from 219 (160-247 [118-274]) s in Phase 1 to 228 (151-501 [111-2661]) s in Phase 2. User feedback was positive and overall usability high (Phase 1--82%, Phase 2--78%).
Collapse
Affiliation(s)
- J Hudson
- Department of Anaesthesiology, Pharmacology, and Therapeutics, University of British Columbia, British Columbia Children's Hospital, Vancouver, Canada.
| | | | | | | | | | | | | | | |
Collapse
|
49
|
Barresi R, Waele LD, Henderson M, Hudson J, Horrocks I, Longman C, Bushby K. G.O.6 Autosomal recessive desminopathy with desmin-null mutations presenting in childhood. Neuromuscul Disord 2012. [DOI: 10.1016/j.nmd.2012.06.237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
50
|
Machado P, Hudson J, Miller A, Morrow J, Parton M, Bushby K, Hanna M. 097 Valosin Containing Protein (VCP) and Myofibrillar Myopathies (MFM) genes' mutations are not associated with sporadic Inclusion Body Myositis (sIBM). J Neurol Psychiatry 2012. [DOI: 10.1136/jnnp-2011-301993.139] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|